State-of-the-art strategies for targeting the DNA damage response in cancer

PG Pilié, C Tang, GB Mills, TA Yap - Nature reviews Clinical oncology, 2019 - nature.com
Genomic instability is a key hallmark of cancer that arises owing to defects in the DNA
damage response (DDR) and/or increased replication stress. These alterations promote the …

Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy

R Du, C Huang, K Liu, X Li, Z Dong - Molecular cancer, 2021 - Springer
Aurora kinase A (AURKA) belongs to the family of serine/threonine kinases, whose
activation is necessary for cell division processes via regulation of mitosis. AURKA shows …

Genetic and biological hallmarks of colorectal cancer

J Li, X Ma, D Chakravarti, S Shalapour… - Genes & …, 2021 - genesdev.cshlp.org
Colorectal cancer has served as a genetic and biological paradigm for the evolution of solid
tumors, and these insights have illuminated early detection, risk stratification, prevention …

The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review

K Liu, M Zheng, R Lu, J Du, Q Zhao, Z Li, Y Li… - Cancer Cell …, 2020 - Springer
One of the most prominent features of tumor cells is uncontrolled cell proliferation caused by
an abnormal cell cycle, and the abnormal expression of cell cycle-related proteins gives …

DNA methyltransferases in cancer: biology, paradox, aberrations, and targeted therapy

J Zhang, C Yang, C Wu, W Cui, L Wang - Cancers, 2020 - mdpi.com
DNA methyltransferases are an essential class of modifiers in epigenetics. In mammals,
DNMT1, DNMT3A and DNMT3B participate in DNA methylation to regulate normal …

Chromatin remodellers as therapeutic targets

HA Malone, CWM Roberts - Nature Reviews Drug Discovery, 2024 - nature.com
Large-scale cancer genome sequencing studies have revealed that chromatin regulators
are frequently mutated in cancer. In particular, more than 20% of cancers harbour mutations …

Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy

M Wanior, A Krämer, S Knapp, AC Joerger - Oncogene, 2021 - nature.com
Multi-subunit ATPase-dependent chromatin remodelling complexes SWI/SNF
(switch/sucrose non-fermentable) are fundamental epigenetic regulators of gene …

Aurora kinase A, a synthetic lethal target for precision cancer medicine

PK Mou, EJ Yang, C Shi, G Ren, S Tao… - Experimental & Molecular …, 2021 - nature.com
Recent advances in high-throughput sequencing technologies and data science have
facilitated the development of precision medicine to treat cancer patients. Synthetic lethality …

PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase

B Adhikari, J Bozilovic, M Diebold, JD Schwarz… - Nature chemical …, 2020 - nature.com
The mitotic kinase AURORA-A is essential for cell cycle progression and is considered a
priority cancer target. Although the catalytic activity of AURORA-A is essential for its mitotic …

ARID1A Mutations Are Associated with Increased Immune Activity in Gastrointestinal Cancer

L Li, M Li, Z Jiang, X Wang - Cells, 2019 - mdpi.com
Because traditional treatment strategies for advanced gastrointestinal (GI) cancers often
have a limited therapeutic effect, immunotherapy could be a viable approach for the therapy …